Epidermal growth factor receptor inhibitor-related paronychia
10.35541/cjd.20210858
- VernacularTitle:表皮生长因子受体抑制剂相关甲沟炎的研究进展
- Author:
Zixin HU
1
;
Kexin TAN
;
Huijing DONG
;
Xu ZHANG
;
Yixuan YU
;
Xingyu LU
;
Jia LI
;
Huijuan CUI
Author Information
1. 北京中医药大学，北京 100029
- Publication Type:Journal Article
- Keywords:
Paronychia;
Epidermal growth factor receptor inhibitors;
Cutaneous adverse reactions
- From:
Chinese Journal of Dermatology
2025;58(3):276-281
- CountryChina
- Language:Chinese
-
Abstract:
Epidermal growth factor receptor inhibitor (EGFRI) -related paronychia is a condition clearly related to EGFRI therapy, characterized by periungual erythema, edema, purulent exudates, periungual or subungual granulomatous lesions, and sometimes accompanied by thinning, fragility or even splitting and seperation of nail plates. Inhibition of epidermal function, inflammation and secondary infections, as well as angiogenesis are the core processes in the occurrence and development of EGFRI-related paronychia. This review summarizes epidemiology, pathogenesis, clinical manifestations, prevention and treatment of EGFRI-related paronychia.
